[Federal Register Volume 62, Number 182 (Friday, September 19, 1997)] [Notices] [Page 49248] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-24884] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel meeting: Name of SEP: HLA Genotyping. Date: October 8, 1997. Time: 3:00 p.m. Contact Person: William Elzinga, Ph.D., Scientific Review Administrator, Review Branch, NIDDK, Natcher Building, Room 6as-37A, National Institutes of Health, Bethesda, Maryland 20892-6600, Phone: (301) 594-8895. Purpose/Agenda: To review and evaluate grant applications. This meeting will be closed in accordance with the provisions set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. Applications and/or proposals and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the applications and/or proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. (Catalog of Federal Domestic Assistance Program No. 93.847-849, Diabetes, Endocrine and Metabolic Diseases; Digestive Diseases and Nutrition; and Kidney Diseases, Urology and Hematology Research, National Institutes of Health) Dated: September 12, 1997. LaVerne Y. Stringfield, Committee Management Officer, NIH. [FR Doc. 97-24884 Filed 9-18-97; 8:45 am] BILLING CODE 4140-01-M